Indian generic drugmaker Lupin reported a bigger-than-expected rise in its third-quarter profit on Wednesday, helped by strong demand in its North American and domestic markets. .
The market has cheered the development, which comes ahead of the timeline set by Lupin s management at its March quarter earnings call, much more needs to be done before the company s fortunes turn around meaningfully.
Glenmark Pharma launches COPD treatment inhaler in UK indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Glenmark Pharma launches Tiogiva in UK business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.